A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval.
Adult
Aged
Cross-Sectional Studies
Decision Trees
Diabetes Mellitus
/ physiopathology
Diabetic Retinopathy
/ diagnosis
Electroretinography
/ instrumentation
Equipment Design
Female
Humans
Male
Mass Screening
Middle Aged
ROC Curve
Reproducibility of Results
Retina
/ physiopathology
Risk Assessment
Risk Factors
Sensitivity and Specificity
decision tree
diabetic retinopathy
diagnostic model
electroretinogram
risk factor
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
11
2020
accepted:
11
03
2021
entrez:
29
4
2021
pubmed:
30
4
2021
medline:
28
12
2021
Statut:
epublish
Résumé
To construct a proper model to screen for diabetic retinopathy (DR) with the RETeval. This was a cross-sectional study. Two hundred thirty-two diabetic patients and seventy controls were recruited. The DR risk assessment protocol was performed to obtain subjects' DR risk score using the RETeval. Afterwards, the receiver operating characteristic (ROC) curve was used to determine the best cutoff for diagnosing DR. Random forest and decision tree models were constructed. With increasing DR severity, the DR score gradually increased. When the DR score was used to diagnose DR, the ROC curve had an area under the curve of 0.881 (95% confidence interval: 0.836-0.927, P < 0.001), with a best cutoff value of 22.95, a sensitivity of 74.3% (95 CI: 66.0%~82.6%), and a specificity of 90.6% (95 CI: 83.7% ~94.8%). The top four risk factors selected by the random forest were used to construct the decision tree for diagnosing DR, which had a sensitivity of 93.3% (95% CI: 86.3%~97.0%) and a specificity of 80.3% (95% CI: 72.1% ~86.6%). The DR risk assessment protocol combined with the decision tree model was innovatively used to evaluate the risk of DR, improving the sensitivity of diagnosis, which makes this method more suitable than the current protocol for DR screening.
Identifiants
pubmed: 33912134
doi: 10.3389/fendo.2021.632457
pmc: PMC8074966
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
632457Informations de copyright
Copyright © 2021 Deng, Li, Zeng, Wang, Liang and Lan.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Diabetes Care. 2017 Sep;40(9):1285
pubmed: 28705833
Diabetes Care. 2002 Aug;25(8):1320-5
pubmed: 12145228
Transl Vis Sci Technol. 2020 Oct 06;9(11):2
pubmed: 33101780
BMC Ophthalmol. 2016 Mar 05;16:22
pubmed: 26944722
Stat Med. 1998 Apr 30;17(8):857-72
pubmed: 9595616
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5116-24
pubmed: 17065533
Ophthalmology. 2002 Jul;109(7):1225-34
pubmed: 12093643
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14
pubmed: 19896746
Doc Ophthalmol. 2012 Feb;124(1):1-13
pubmed: 22038576
J Med Assoc Thai. 2010 Oct;93(10):1196-9
pubmed: 20973323
Doc Ophthalmol. 2018 Dec;137(3):131-141
pubmed: 30334119
J Am Soc Hypertens. 2018 Aug;12(8):579.e1-579.e73
pubmed: 30219548
Doc Ophthalmol. 2011 Dec;123(3):193-8
pubmed: 22057379
Medicine (Baltimore). 2018 Dec;97(50):e13678
pubmed: 30558076
Kidney Int. 2019 Mar;95(3):636-646
pubmed: 30709663
Doc Ophthalmol. 1993;84(1):61-9
pubmed: 8223111
Acta Ophthalmol. 2015 Sep;93(6):e465-8
pubmed: 25597703
Clin Ophthalmol. 2018 Mar 01;12:427-432
pubmed: 29535500
Prog Retin Eye Res. 2011 Jan;30(1):18-53
pubmed: 20868767
Biomed Res Int. 2017;2017:8539747
pubmed: 28713831
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3684-90
pubmed: 26047169
J Glob Health. 2018 Jun;8(1):010803
pubmed: 29899983
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
Sci Rep. 2016 Nov 08;6:36591
pubmed: 27824158
Diabetes Care. 2012 Apr;35(4):803-8
pubmed: 22338100
J Clin Invest. 1998 Aug 15;102(4):783-91
pubmed: 9710447
J Comp Neurol. 1990 Feb 22;292(4):497-523
pubmed: 2324310
Transl Vis Sci Technol. 2014 Jun 19;3(3):6
pubmed: 24959388
J Ophthalmol. 2015;2015:401281
pubmed: 26576292
Eye (Lond). 2016 May;30(5):673-9
pubmed: 26869156
Jpn J Ophthalmol. 1993;37(2):204-10
pubmed: 8230847
Ophthalmology. 2011 Apr;118(4):649-55
pubmed: 21035872
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Diabetologia. 1983 May;24(5):330-2
pubmed: 6873511
N Engl J Med. 2010 Mar 25;362(12):1090-101
pubmed: 20335585
Doc Ophthalmol. 2010 Oct;121(2):135-46
pubmed: 20665068
Clin Ophthalmol. 2016 Oct 17;10:2031-2034
pubmed: 27799729
Mediators Inflamm. 2013;2013:274726
pubmed: 24347823
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H738-49
pubmed: 27473938
Doc Ophthalmol. 1992;80(1):1-11
pubmed: 1505334
Nat Rev Dis Primers. 2016 Mar 17;2:16012
pubmed: 27159554
Doc Ophthalmol. 2020 Jun;140(3):211-220
pubmed: 31720980
J Diabetes Complications. 2016 Apr;30(3):524-32
pubmed: 26803474
PLoS One. 2019 Feb 20;14(2):e0212574
pubmed: 30785930
Exp Eye Res. 2002 May;74(5):615-25
pubmed: 12076083
PLoS One. 2012;7(9):e45264
pubmed: 23028893
Br J Ophthalmol. 2019 Dec;103(12):1747-1752
pubmed: 30674454
Br J Ophthalmol. 2017 Dec;101(12):1591-1595
pubmed: 28855195